Internal Reference Number: FOI_9324
Date Request Received: 01/04/2026 00:00:00
Date Request Replied To: 29/04/2026 00:00:00
This response was sent via: By Email
Request Summary: Haem & PPC
Request Category: Companies
| Question Number 1: Haem Questionnaires Haemophilia A In the past 12 months [latest 12 months available], how many patients have been diagnosed with the each of the following conditions in your Trust: Haemophilia A Acquired Haemophilia A (AHA) Congenital Haemophilia A with inhibitors CHAwI) | |
| Answer To Question 1: Please see results below for the latest 12 months (April 2025 - March 2026). We were unable to search for 'Congenital Haemophilia A with inhibitors CHAwI' as there is no relevant ICD-10 diagnosis code for this. Diagnosis Total Unique patients diagnosed Acquired Haemophilia A <= 5 Haemophilia A 16 Congenital Haemophilia A with inhibitors CHAwI N/A (no code) | |
| Question Number 2: In the last twelve months[latest 12 months available], how many pts with Haemophilia A, have been treated with each of the following products in your Trust: Factor Eight Inhibitor Bypass Activity (FEIBA) Hemlibra (standalone) Hemlibra in combination with NovoSeven RT Hemlibra in combination with Cevenfacta NovoSeven RT Obizur Cevenfacta | |
| Answer To Question 2: 0 results | |
| Question Number 3: In the last twelve months[latest 12 months available], how many patients with Acquired Haemophilia A, have been treated with each of the following products in your Trust: Factor Eight Inhibitor Bypass Activity (FEIBA) NovoSeven RT Obizur Cevenfacta | |
| Answer To Question 3: 0 results | |
| Question Number 4: In the last twelve months[latest 12 months available], how many pts with Congenital Haemophilia A with Inhibitors have been treated with each of the following products in your Trust? Factor Eight Inhibitor Bypass Activity (FEIBA) Hemlibra (standalone) Hemlibra in combination with NovoSeven RT Hemlibra in combination with Cevenfacta Hemlibra in combination with FEIBA Helimbra in combination with Factor VIII NovoSeven RT Obizur Cevenfacta | |
| Answer To Question 4: Unable to answer for 'Congenital Haemophilia A with inhibitors CHAwI' as there is no relevant ICD-10 diagnosis code for this. | |
| Question Number 5: Prothrombin Complex Concentrate (PCC) What is the total Prothrombin Complex Concentrate usage in International Units (IUs) for your Trust over the last 12 months [latest 12 months available] for each of the products below in your Trust? Prothromplex Beriplex Octaplex | |
| Answer To Question 5: The Trust swapped LIMS system last year. So the information provided is from Jan 25 – Sept 25. • Octaplex – 500IU – Total from Jan 25 to Sept 25 = 12500IU • Octaplex – 1000IU – Total from Jan 25 to Sept 25 = 48000IU | |
| Question Number 6: Can you share the Prothrombin Complex Concentrate usage in International Units for your Trust in the last 12 months [latest 12 months available] within each of the following departments, and which PCC is used? Prothromplex Beriplex Octaplex Departments Cardio-speciality General Medicine General surgery Haematology Emergency care Any other | |
| Answer To Question 6: Cardio-speciality: N/A General Medicine • Octaplex – 500IU – Total = 1000IU • Octaplex – 1000IU – Total = 14000IU General surgery • Octaplex – 500IU – Total = 1500IU • Octaplex – 1000IU – Total = 5000IU Haematology • Octaplex – 500IU – Total = IU • Octaplex – 1000IU – Total = 4000IU Emergency care • Octaplex – 500IU – Total = 8000IU • Octaplex – 1000IU – Total = 20000IU Any other • Octaplex – 500IU – Total = 6000IU • Octaplex – 1000IU – Total = 15000IU | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
